MENU
SION
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Sionna Therapeutics (SION) Ownership - Who owns Sionna Therapeutics?
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.28B
P/E Ratio
N/A
Total Cash
262.57M
Projected Growth
N/A
Total Debt
9.24M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
5.95
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
SION
Capitalization
1.28B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
263M
Total Cash/Share
5.95
Total Debt
9.24M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
336M
P/B Ratio
3.80
Cash Flow
N/A
Earnings
-1.72
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
44K
Current Ratio
35.33
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-87.04M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-21.54
Shares Held By Institutions
698M
Shares Outstanding - Current
44.1M
Total Liabilities
15.6M
Total Volume MTD
N/A
Value
N/A
Gain YTD
N/A
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SION showed earnings on August 11, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information